Takahiro Yamauchi Selected Research

Drug Therapy (Chemotherapy)

1/2024	Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial.
9/2023	Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-CD20 antibodies.
9/2023	The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma.
11/2022	Ewing sarcoma with very late metastasis in the skull: a case report.
10/2022	Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series.
8/2022	Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
1/2022	Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
3/2021	Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
1/2021	Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.
11/2020	Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Yamauchi Research Topics

Disease

35	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 11/2003
27	Neoplasms (Cancer) 03/2024 - 02/2002
25	Leukemia 03/2024 - 06/2002
11	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 11/2006
10	Lymphoma (Lymphomas) 09/2023 - 03/2007
8	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 06/2010
7	Neutropenia 01/2024 - 03/2002
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2023 - 11/2012
6	Acute Promyelocytic Leukemia 01/2023 - 02/2003
6	Multiple Myeloma 01/2022 - 01/2014
5	Febrile Neutropenia 10/2022 - 12/2013
5	Pneumonia (Pneumonitis) 08/2021 - 05/2009
5	Disease Progression 05/2021 - 09/2012
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2020 - 02/2010
5	Hyperuricemia 01/2015 - 04/2008
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2024 - 12/2017
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 07/2007
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 12/2018
4	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2013
4	Infections 02/2021 - 03/2002
4	Nausea 04/2019 - 12/2013
4	Disseminated Intravascular Coagulation 11/2018 - 01/2011
4	Tumor Lysis Syndrome 12/2016 - 10/2014
4	Carcinogenesis 07/2011 - 05/2007
4	Colonic Neoplasms (Colon Cancer) 07/2011 - 03/2010
3	Anemia 01/2020 - 12/2013
3	Vomiting 04/2019 - 11/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 06/2008
2	Hematologic Diseases (Blood Diseases) 09/2023 - 04/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2023 - 02/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 10/2022
2	Liver Diseases (Liver Disease) 10/2022 - 10/2017
2	Diarrhea 10/2022 - 04/2019
2	Fever (Fevers) 03/2021 - 01/2017
2	Bacteremia 02/2021 - 04/2013
2	Sepsis (Septicemia) 02/2021 - 06/2002
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Hematoma 10/2018 - 10/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 03/2002
2	Hemorrhage 10/2017 - 01/2011
2	Pancytopenia 01/2017 - 10/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 10/2014 - 04/2014

Drug/Important Bio-Agent (IBA)

16	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024 - 02/2003
8	Uric Acid (Urate)IBA 05/2015 - 04/2008
6	venetoclaxIBA 01/2022 - 10/2020
6	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 06/2002
6	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 11/2002
6	ErbB Receptors (EGF Receptor)IBA 12/2011 - 06/2010
5	Bortezomib (Velcade)FDA Link 01/2022 - 12/2016
5	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 07/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 12/2013
4	Rituximab (Mabthera)FDA Link 03/2024 - 01/2014
4	Azacitidine (5 Azacytidine)FDA Link 03/2023 - 05/2021
4	Clofarabine (Clolar)FDA Link 10/2020 - 09/2011
4	Phosphotransferases (Kinase)IBA 11/2015 - 06/2008
4	Carmustine (FIVB)FDA Link 08/2015 - 11/2002
4	9-arabinofuranosylguanineIBA 09/2014 - 02/2010
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014 - 03/2005
4	Gemcitabine FDA Link 12/2011 - 11/2006
4	Epidermal Growth Factor (EGF)IBA 07/2011 - 03/2010
4	Proteins (Proteins, Gene)FDA Link 06/2010 - 04/2008
3	Messenger RNA (mRNA)IBA 09/2023 - 10/2012
3	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 02/2015
3	nelarabine (506U78)FDA Link 10/2019 - 02/2010
3	forodesineIBA 01/2019 - 09/2014
3	Dacarbazine (DIC)FDA LinkGeneric 11/2018 - 01/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2017 - 02/2002
3	Febuxostat FDA Link 01/2015 - 10/2014
3	p38 Mitogen-Activated Protein KinasesIBA 11/2011 - 06/2010
3	triphosphoric acid (triphosphate)IBA 09/2011 - 11/2006
3	Cyclin D1IBA 07/2011 - 03/2008
3	rho-Associated KinasesIBA 07/2011 - 03/2010
2	Bendamustine Hydrochloride FDA Link 03/2024 - 01/2014
2	EnzymesIBA 03/2024 - 04/2019
2	Tyrosine Kinase InhibitorsIBA 07/2023 - 09/2010
2	alovudineIBA 01/2023 - 02/2019
2	Gemtuzumab (Mylotarg)FDA Link 03/2021 - 10/2014
2	Purine-Nucleoside PhosphorylaseIBA 01/2019 - 09/2014
2	ThrombomodulinIBA 11/2018 - 01/2011
2	SurvivinIBA 12/2017 - 09/2012
2	R-CHOP protocolIBA 12/2017 - 11/2012
2	Methotrexate (Mexate)FDA LinkGeneric 10/2017 - 02/2014
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 02/2014
2	Becaplermin (PDGF-BB)FDA Link 07/2016 - 04/2012
2	Platelet-Derived Growth FactorIBA 07/2016 - 04/2012
2	Temozolomide (Temodar)FDA LinkGeneric 08/2015 - 07/2008
2	purineIBA 12/2014 - 01/2014
2	Xanthine OxidaseIBA 12/2014 - 10/2014
2	Dasatinib (BMS 354825)FDA Link 02/2014 - 06/2011
2	Alanine Transaminase (SGPT)IBA 12/2013 - 05/2007

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
31	Therapeutics 03/2024 - 03/2002
3	Hematopoietic Stem Cell Transplantation 10/2022 - 10/2013
3	Induction Chemotherapy 05/2021 - 01/2011
3	Remission Induction 01/2011 - 06/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2023 - 03/2008
2	Transplantation 11/2023 - 01/2017
2	Craniotomy 09/2023 - 10/2017
2	Radiotherapy 10/2017 - 05/2009